Tag: gene therapy market forecast

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Gene Therapy Market Expected to Grow Between 2025 And 2029?

The market size for gene therapy has experienced significant expansion in the recent past. The magnitude is projected to escalate from a whopping $12.52 billion in 2024, reaching up to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors contributing to growth during the historic period include an increase in pharmaceutical research and development spending, surge in collaborations between the private sector and government, state-level investments, and an upsurge in instances of spinal muscular atrophy.

The gene therapy market is projected to experience significant expansion in the coming years, anticipated to reach $31.48 billion by 2029 with a remarkable compound annual growth rate (CAGR) of 17.8%. The expansion anticipated in the projection period finds its roots in the escalation of cancer incidences, the expanding elderly demographic, heightened pharmaceutical sector investment in R&D, and an amplified emphasis on gene therapy. Upcoming market trends in the projection time frame encompass improving business functions via regulatory approvals, augmenting commercial activities via strategic alliances and associations, stretching business scope with strategic investments, and fortifying operational capacities via business enlargement.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gene Therapy Market?

The significant increase in occurrences of cancer and other targeted diseases necessitates effective treatments, thus fueling the expansion of the gene therapy market. The escalating cancer instances worldwide are predicted to further the growth of the gene therapy market in the upcoming period. For example, the American Cancer Society reported in January 2022 that there are likely to be approximately 1.9 million fresh cancer cases and about 609,360 cancer-associated fatalities in the US alone, averaging about 1,670 deaths per day. The top four prevalent types of cancer globally; lung, prostate, bowel, and female breast cancer, make up 43 percent of all new cancer diagnoses. Therefore, the global surge in cancer occurrence rate is predicted to propel the demand for the gene therapy market in the ensuing years. Gene therapy serves as one of the most potent treatments in oncology, where new genes are infused into a cancerous cell or its accompanying tissue to either induce cell death or inhibit cancer proliferation.

Which Key Market Segments Comprise the Gene Therapy Market and Drive Its Revenue Growth?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Areas Are Leading Regions in the Gene Therapy Market Expansion Across the Globe?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theGene Therapy Market Over the Coming Years?

The adoption of machine learning and artificial intelligence within the gene therapy market is slowly but steadily increasing. Artificial Intelligence (AI) is essentially the replication of human cognition by machines, while machine learning operates as a subset of AI. Applications of machine learning and AI within gene therapy help companies perform in-depth data analyses, generate insights into tumor-immune cell interactions, and yield more precise evaluations of tissue specimens, an aspect often subject to differing interpretations. Case in point, Form Bio, a life-science software firm based in the US, unveiled FORMsightAI in May 2023. This novel AI solution predicts and optimizes the production outputs of both cell and gene therapy constructs. The FORMsightAI package merges innovative, flexible AI models with Form Bio’s foundational platform and a team of accomplished experts in computational life sciences with a depth of knowledge in biology, bioinformatics, and data science. FORMsightAI tackles frequent challenges such as construct truncations and manufacturing contaminations often experienced by cell and gene therapy developers. These issues majorly contribute to low production yields, delayed market entry, and therapeutic safety concerns.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Conceptually Defined?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Fast Is The Gene Therapy Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size for gene therapy has experienced significant expansion in the recent past. The magnitude is projected to escalate from a whopping $12.52 billion in 2024, reaching up to $16.36 billion by 2025, marking a compound annual growth rate (CAGR) of 30.7%. Factors contributing to growth during the historic period include an increase in pharmaceutical research and development spending, surge in collaborations between the private sector and government, state-level investments, and an upsurge in instances of spinal muscular atrophy._x000D_

_x000D_

The gene therapy market is projected to experience significant expansion in the coming years, anticipated to reach $31.48 billion by 2029 with a remarkable compound annual growth rate (CAGR) of 17.8%. The expansion anticipated in the projection period finds its roots in the escalation of cancer incidences, the expanding elderly demographic, heightened pharmaceutical sector investment in R&D, and an amplified emphasis on gene therapy. Upcoming market trends in the projection time frame encompass improving business functions via regulatory approvals, augmenting commercial activities via strategic alliances and associations, stretching business scope with strategic investments, and fortifying operational capacities via business enlargement._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Gene Therapy Market?#_x000D_

The significant increase in occurrences of cancer and other targeted diseases necessitates effective treatments, thus fueling the expansion of the gene therapy market. The escalating cancer instances worldwide are predicted to further the growth of the gene therapy market in the upcoming period. For example, the American Cancer Society reported in January 2022 that there are likely to be approximately 1.9 million fresh cancer cases and about 609,360 cancer-associated fatalities in the US alone, averaging about 1,670 deaths per day. The top four prevalent types of cancer globally; lung, prostate, bowel, and female breast cancer, make up 43 percent of all new cancer diagnoses. Therefore, the global surge in cancer occurrence rate is predicted to propel the demand for the gene therapy market in the ensuing years. Gene therapy serves as one of the most potent treatments in oncology, where new genes are infused into a cancerous cell or its accompanying tissue to either induce cell death or inhibit cancer proliferation._x000D_

_x000D_

#Which Key Market Segments Comprise the Gene Therapy Market and Drive Its Revenue Growth?#_x000D_

The gene therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy_x000D_

2) By Vector: Viral Vector, Non-Viral Vector_x000D_

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders_x000D_

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations _x000D_

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Gene Therapy Market Expansion Across the Globe?#_x000D_

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Are the Key Market Trends in theGene Therapy Market Over the Coming Years?#_x000D_

The adoption of machine learning and artificial intelligence within the gene therapy market is slowly but steadily increasing. Artificial Intelligence (AI) is essentially the replication of human cognition by machines, while machine learning operates as a subset of AI. Applications of machine learning and AI within gene therapy help companies perform in-depth data analyses, generate insights into tumor-immune cell interactions, and yield more precise evaluations of tissue specimens, an aspect often subject to differing interpretations. Case in point, Form Bio, a life-science software firm based in the US, unveiled FORMsightAI in May 2023. This novel AI solution predicts and optimizes the production outputs of both cell and gene therapy constructs. The FORMsightAI package merges innovative, flexible AI models with Form Bio’s foundational platform and a team of accomplished experts in computational life sciences with a depth of knowledge in biology, bioinformatics, and data science. FORMsightAI tackles frequent challenges such as construct truncations and manufacturing contaminations often experienced by cell and gene therapy developers. These issues majorly contribute to low production yields, delayed market entry, and therapeutic safety concerns._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report_x000D_

_x000D_

#How Is the Gene Therapy Market Conceptually Defined?#_x000D_

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Forecast for the Gene Therapy Market from 2024 to 2025?#_x000D_

Over recent years, the gene therapy market has experienced tremendous expansion. It is expected to elevate from a value of $12.52 billion in 2024 to $16.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 30.7%. The swell in growth during the historical period can be ascribed to factors such as heightened pharmaceutical R&D spending, an increase in public-private collaborations, governmental funding, and a surge in instances of spinal muscular atrophy._x000D_

_x000D_

#What Is the Projected Market Size of the Gene Therapy Market?#_x000D_

Rapid expansion is anticipated for the gene therapy market in the coming years, with projections showing a leap to $31.48 billion by 2029, characterized by a compound annual growth rate (CAGR) of 17.8%. Factors contributing to this predicted growth during the forecast period include a surge in cancer cases, an aging demographic, increased pharmaceutical R&D investment and a stronger emphasis on gene therapy. Key trends expected to emerge during the forecast period include acquiring regulatory permissions to improve business functions, fortifying business activities via strategic alliances and partnerships, growing business capabilities via strategic takeovers, and bolstering operational competencies through business expansions._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp_x000D_

_x000D_

#Who are the Major Competitors in the Gene Therapy Market Outlook?#_x000D_

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi_x000D_

_x000D_

#What Is Fueling Growth in the Gene Therapy Market?#_x000D_

The escalating incidence of cancer and other specific diseases is necessitating compelling solutions, resulting in a surge in the gene therapy market’s growth. A global increase in cancer cases can be expected to stimulate the expansion of this market throughout the upcoming years. For instance, the American Cancer Society revealed in January 2022 that the US is likely to see about 1.9 million new cancer diagnoses and approximately 609,360 deaths related to cancer, translating to around 1,670 deaths daily. The four most prevalent types of cancer globally, lung, prostate, bowel, and female breast cancer, represent 43 percent of all new cancer instances. Consequently, the global surge in the rate of cancer incidences is predicted to spark an increased demand for the gene therapy market in the near future. Known as one of the most efficient treatments in oncology, gene therapy introduces new genes within a cancerous cell or its surrounding tissue, effectively inducing cell death or inhibiting the cancer growth._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp_x000D_

_x000D_

#Which Gene Therapy Market Segments Are Growing the Fastest?#_x000D_

The gene therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy_x000D_

2) By Vector: Viral Vector, Non-Viral Vector_x000D_

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders_x000D_

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations_x000D_

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques_x000D_

_x000D_

#Which Industry Trends Are Shaping the Future of the Gene Therapy Market?#_x000D_

Machine learning and artificial intelligence are steadily becoming more prevalent in the gene therapy market. AI emulates human intelligence in machines, which are configured to demonstrate their inherent intelligence. Machine learning, a component of AI, enables companies in the gene therapy market to thoroughly review all pertinent data, obtain insights into tumor and immune cell interactions, and provide a more precise assessment of tissue samples, a common source of conflict among different evaluators. For example, Form Bio, a US-based software company specializing in life sciences, introduced FORMsightAI, a novel AI-powered solution set for forecasting and improving cell and gene therapy constructs manufacturing outputs, in May 2023. This comprehensive solution merges state-of-the-art, flexible AI models with Form Bio’s foundational platform and a competent team of computational life sciences professionals with expertise in biology, bioinformatics, and data science. FORMsightAI tackles common challenges encountered by cell and gene therapy developers like construct truncations and manufacturing contaminations, which are primary reasons for unacceptable low manufacturing yields, delayed market timelines, and therapeutic safety issues._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report_x000D_

_x000D_

#Which Countries Are Leading the Gene Therapy Market?#_x000D_

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the gene therapy market, and how is it changing globally?_x000D_

2. Who are the major companies in the gene therapy market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the gene therapy market right now?_x000D_

4. Which products or customer segments are growing the most in the gene therapy market?_x000D_

5. What factors are helping or slowing down the growth of the gene therapy market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the gene therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Projected CAGR for the Gene Therapy Market Size from 2025 to 2034?

In the past few years, there has been a remarkable growth in the size of the gene therapy market. It is projected to escalate from $12.52 billion in 2024 to $16.36 billion in 2025, marking a compound annual growth rate (CAGR) of 30.7%. The noteworthy growth during the historic period is credited to factors such as increased pharmaceutical R&D spending, proliferation of public-private collaborations, government funding, and a surge in instances of spinal muscular atrophy.

Accelerated expansion is anticipated in the gene therapy market size over the next few years. With a compound annual growth rate (CAGR) of 17.8%, it is projected to reach $31.48 billion by 2029. The projected growth during this period is largely due to the escalating number of cancer cases, the aging population swell, rising expenditure in pharmaceutical research and development, and an intensifying focus on gene therapy. Key trends for the forecast period encompass procuring regulatory approvals to enhance business procedures, fortifying business activities via strategic collaborations and partnerships, broadening business prowess through tactical acquisitions, and bolstering operational capacities through business expansions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

What are the Fundamental Drivers and Innovations Shaping the Gene Therapy Market?

The growing incidence of cancer and other targeted diseases is necessitating efficient treatments, thereby fueling the gene therapy market’s expansion. The surge in global cancer rates is expected to significantly boost the gene therapy market over the projection period. For example, the American Cancer Society predicts that in January 2022, there may be around 1.9 million new cancer cases and 609,360 cancer-related deaths in the US, with approximately 1,670 deaths occurring each day. Lung, prostate, bowel, and female breast cancer are globally the four most common cancer types, comprising 43 percent of all newly diagnosed cancer cases. Hence, the global increase in cancer cases is presumed to drive demand for the gene therapy market in the coming years. Gene therapy, one of the most efficient cancer treatments, involves introducing new genes into a cancer cell or its surrounding tissue to trigger cell death or slow cancer growth.

How Is the Gene Therapy Market Segmented?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Regions Are Driving the Next Phase of the Gene Therapy Market Growth?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Gene Therapy Market?

The gene therapy market is slowly but surely embracing machine learning and artificial intelligence. AI, which replicates human intelligence in machines, and machine learning, a component of AI, are proving to be beneficial in the deep analysis of significant data. These technologies are providing critical insights into tumor-immune cell interactions and offer a more precise assessment of tissue samples, a topic often subject to contention among various evaluators. For example, in May 2023, FORMsightAI, a fresh AI-driven solution for forecasting and enhancing cell and gene therapy constructs’ production outputs was introduced by US-based Form Bio. Leveraging advanced AI models, Form Bio’s foundational platform, and experts in computational life science, FORMsightAI is a comprehensive solution. It addresses key challenges in cell and gene therapy development like construct truncations and manufacturing contaminations, which often lead to low manufacturing yields, delayed market entry, and safety concerns in therapeutics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

How Is the Gene Therapy Market Defined and What Are Its Core Parameters?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?

The escalating rate of cancer and other targeted diseases is demanding effective remedies, thus fueling the expansion of the gene therapy market. The increasing global cancer incidence will likely foster the growth of the gene therapy market in the years to come. For instance, the American Cancer Society estimated in January 2022 that approximately 1.9 million fresh cancer diagnoses and 609,360 cancer-related deaths would occur in the US in a single year, roughly translating to 1,670 deaths each day. The most prevalent cancer types worldwide include lung, prostate, bowel, and female breast cancer, representing 43 percent of all new cancer diagnoses. Hence, the global surge in cancer rates is likely to stimulate the demand for the gene therapy market in the future. In oncology, gene therapy offers one of the most efficient treatment approaches. The process involves implanting new genes into a cancer cell or its surrounding tissue to induce cell death or inhibit cancer growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

#What Growth Opportunities Will Drive the Gene Therapy Market’s CAGR Through 2034?

In the past few years, the market size of gene therapy has seen a significant surge. The market, which is currently valued at $12.52 billion in 2024, is projected to escalate to $16.36 billion in 2025, with a compound annual growth rate (CAGR) of 30.7%. Factors such as an increase in pharmaceutical R&D spending, augmented public-private collaborations, governmental funding, and a spike in instances of spinal muscular atrophy have heavily contributed to this historical growth phase.

The gene therapy market is poised for rapid expansion in the upcoming years. The anticipated growth will have it reach a worth of $31.48 billion by 2029, with a compound annual growth rate (CAGR) of 17.8%. This predicted growth during the forecast period is largely a result of factors such as a spike in cancer incidents, an aging global population, increased expenditure in research and development in the pharmaceutical segment, and heightened attention on gene therapy. Key trends forecasted for this period include obtaining regulatory approvals to enhance business operations, fortifying business activity via strategic collaborations and partnerships, broadening business capacity through strategic acquisitions, and intensifying operational capabilities through business expansion.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

What Are the Most Significant Market Trends Transforming theGene Therapy Market?

Machine learning and artificial intelligence are slowly but surely making their mark in the gene therapy market. AI mimics human cognition in machines, which are programmed to demonstrate inherent intelligence, with machine learning forming a component of this. It assists companies in the gene therapy market in conducting in-depth data analysis, providing insights on tumor and immune cell interactions, and delivering a more precise appraisal of tissue samples, often a point of contention among various evaluators. Take, for instance, in May 2023, Form Bio, a US-based biotechnology software firm, unveiled its revolutionary AI-powered solution, FORMsightAI, designed to predict and enhance the production outputs of cell and gene therapy constructs. This comprehensive solution integrates revolutionary, flexible AI models with Form Bio’s integral platform and a proficient team of computational life science experts possessing backgrounds in biology, bioinformatics, and data science. FORMsightAI takes on frequent problems encountered by cell and gene therapy developers, such as construct truncations and manufacturing contaminations, which are primarily responsible for unacceptably low production yields, drawn-out market-ready timelines, and issues concerning therapeutic safety.

What Are the Top Market Players Propelling the Growth of theGene Therapy Industry?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Primary Segments of the Gene Therapy Market Are Driving Growth and Industry Transformations?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3395&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Gene Therapy Market?# Market?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Gene Therapy Market 2025, By The Business Research Company:

Colorectal Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report

Thyroid Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-drugs-global-market-report

Hematology Analyzers and Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the gene therapy market grown in recent years?

In recent times, the growth of the gene therapy market size has been exponential. The market is projected to expand from $12.52 billion in 2024 to $16.36 billion in 2025 with a compound annual growth rate (CAGR) of 30.7%. The historical growth can be traced back to increasing pharmaceutical research and development expenditures, growing public-private collaborations, government funding, and an uptick in spinal muscular atrophy instances.

How is the gene therapy market size expected to evolve during the forecast period?

Anticipated to witness a significant rise in the next couple of years, the market size of geospatial analytics is projected to reach $209.26 billion in 2029 with an impressive compound annual growth rate of 19.0%. The surge during the forecast period can be linked to various factors such as the establishment of smart cities, the implementation of precision farming, healthcare and epidemic tracking, amalgamation with IoT and huge data, as well as environmental preservation initiatives. Key trends during the forecast timeframe include geospatial big data analytics, mobile geospatial applications, blockchain interfaces for spatial data protection, social media combined with geospatial analysis, and urban mobility along with smart city planning.

Get your gene therapy market report here!

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which key drivers are propelling the gene therapy market’s growth?

Significant growth in the gene therapy market is being driven by the escalating incidents of cancer and various other diseases requiring effective treatment. The global increase in cancer cases is expected to contribute to the expansion of the gene therapy market in the projected timeframe. In particular, the American Cancer Society projected in January 2022 that there will be 1.9 million fresh diagnoses of cancer and around 609,360 cancer-related deaths in the United States alone, equating to approximately 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancer are the four most common types, accounting for 43% of all new cases of cancer. Accordingly, the global rise in cancer rates is expected to stimulate demand for the gene therapy market in the coming years. One of the most effective treatment options in oncology is gene therapy, where new genes are introduced into a cancer cell or the surrounding tissue to inhibit cancer growth or result in cell death.

What are the market segments in the gene therapy industry?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which leading companies are shaping the growth of the gene therapy market?

Major companies operating in the gene therapy market include UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, Cipla, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, GE Healthcare, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, Biotchpharma, BrainStorm Cell Therapeutics, Pluristem, Sanofi

What key trends are currently impacting the gene therapy market’s development?

The gene therapy market is increasingly embracing machine learning and artificial intelligence (AI). AI mimics human intelligence within machines that have been programmed to express inherent intelligence. Machine learning, a subset of AI, in tandem with AI assists businesses in the gene therapy arena to conduct exhaustive analysis of pertinent data. They decipher the relationship between tumor and immune cell interactions and provide a more precise assessment of tissue samples, which is often a point of contention among various evaluators. For example, Form Bio, an American life-sciences software firm pioneered FORMsightAI, a novel AI-run solution set for forecasting and enhancing manufacturing yields of cell and gene therapy structures in May 2023. This comprehensive solution merges innovative, flexible AI models with Form Bio’s foundational platform and a seasoned team of computational life sciences experts equipped with know-how in biology, bioinformatics, and data science. FORMsightAI tackles recurrent challenges encountered by cell and gene therapy developers such as construct truncations and manufacturing contaminations. These are leading reasons for deeply unsatisfactory manufacturing yields, protracted market entry timelines, and issues concerning therapeutic safety.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3395

Which geographic areas are influencing the growth of the gene therapy market?

North America was the largest region in the gene therapy market in 2024. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Nucleic Acid Based Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Growth Potential of the Gene Therapy Market, and How Will It Perform by 2034?

The gene therapy market has grown exponentially in recent years. It is projected to expand from $12.52 billion in 2025 to $16.36 billion in 2025, at a CAGR of 30.7%. This rapid growth is driven by higher pharmaceutical R&D spending, rising public-private partnerships, government investments, and an increase in cases of spinal muscular atrophy.

The gene therapy market is projected to experience substantial growth in the coming years, reaching $31.48 billion by 2029 at a compound annual growth rate (CAGR) of 17.8%. This growth is driven by an increase in cancer cases, a rising elderly population, growing pharmaceutical R&D investments, and a heightened focus on gene therapy. Key trends in this period include securing regulatory approvals, enhancing operations through strategic partnerships and collaborations, expanding capabilities via acquisitions, and strengthening operations through business expansions.

What Combination of Drivers Is Leading to Accelerated Growth in the gene therapy Market?

The rising incidence of cancer is expected to drive the gene therapy market. Gene therapy is an effective treatment for cancer by introducing new genes to slow tumor growth. For example, the American Cancer Society projected 1.9 million new cancer diagnoses in 2022. This rise in cancer cases is expected to drive the growth of the gene therapy market.

Explore Comprehensive Insights Into The Global Gene Therapy Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Gene Therapy Market?

Major companies operating in the gene therapy market include:

• UniQure NV_x000D_

• REGENXBIO Inc._x000D_

• Bristol-Myers Squibb_x000D_

• BioMarin Pharmaceuticals Inc._x000D_

• Jazz Pharmaceuticals Inc._x000D_

What Are the Key Emerging Trends in the Gene Therapy Market for the Next Decade?

Machine learning and artificial intelligence (AI) are gaining traction in the gene therapy market, helping companies analyze data and optimize manufacturing processes. For example, in May 2023, Form Bio, a US-based life-sciences software company, launched FORMsightAI, an AI solution designed to address common issues in cell and gene therapy manufacturing.

Secure Your Global Gene Therapy Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

What Major Market Segments Define the Scope and Growth of the Gene Therapy Market?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Regions Are Making a Mark in the Gene Therapy Market Growth?

North America was the largest region in the gene therapy market in 2025. The regions covered in the gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Does the Definition of the Gene Therapy Market Include?

Gene therapy refers to a method for treating or curing sickness that alters a person’s DNA. Gene treatments can function in a variety of ways: putting a healthy copy of the gene in place of a disease-causing gene and putting a defective gene that causes an illness inactive.

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/car-t-therapy-market

Nucleic Acid Based Gene Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: